{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:51:51Z","timestamp":1793238711774,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870166"],"award-info":[{"award-number":["81870166"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022JJ30885"],"award-info":[{"award-number":["2022JJ30885"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e34397","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T14:40:21Z","timestamp":1720622421000},"page":"e34397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["AP-1 inhibitor induces ferroptosis via the PI3K\/AKT pathway in multiple myeloma cells"],"prefix":"10.1016","volume":"10","author":[{"given":"Sishi","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1319-4938","authenticated-orcid":false,"given":"Yunfeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.heliyon.2024.e34397_bib1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrc2189","article-title":"Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets","volume":"7","author":"Hideshima","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e34397_bib2","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34397_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/jama.2021.25306","article-title":"What is multiple myeloma?","volume":"327","author":"Silberstein","year":"2022","journal-title":"JAMA"},{"issue":"10272","key":"10.1016\/j.heliyon.2024.e34397_bib4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34397_bib5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2204925","article-title":"Triplet therapy, transplantation, and Maintenance until progression in myeloma","volume":"387","author":"Richardson","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34397_bib6","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nbt1412","article-title":"Treatment of arthritis with a selective inhibitor of c-Fos\/activator protein-1","volume":"26","author":"Aikawa","year":"2008","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34397_bib7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12967-021-02932-0","article-title":"Inhibition of c-Fos expression attenuates IgE-mediated mast cell activation and allergic inflammation by counteracting an inhibitory AP1\/Egr1\/IL-4 axis","volume":"19","author":"Wang","year":"2021","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34397_bib8","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022779118","article-title":"Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2","volume":"118","author":"Liu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34397_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41388-022-02542-0","article-title":"Hypoxia-induced circADAMTS6 in a TDP43-dependent manner accelerates glioblastoma progression via ANXA2\/NF-kappaB pathway","volume":"42","author":"Zhao","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2024.e34397_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.582923","article-title":"A novel miRNA restores the chemosensitivity of AML cells through targeting FosB","volume":"7","author":"Wang","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.heliyon.2024.e34397_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110687","article-title":"The selective activator protein-1 inhibitor T-5224 regulates the IRF4\/MYC axis and exerts cooperative antimyeloma activity with bortezomib","volume":"384","author":"Tang","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34397_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34397_bib13","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e34397_bib14","article-title":"A novel ferroptosis-related gene signature for predicting prognosis in multiple myeloma","volume":"13","author":"Gao","year":"2023","journal-title":"Front. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e34397_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e34397_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol."},{"issue":"25","key":"10.1016\/j.heliyon.2024.e34397_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301088","article-title":"Inhibition of CDK1 overcomes oxaliplatin resistance by regulating ACSL4-mediated ferroptosis in colorectal cancer","volume":"10","author":"Zeng","year":"2023","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34397_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cac2.12250","article-title":"Ferroptosis in cancer and cancer immunotherapy","volume":"42","author":"Zhao","year":"2022","journal-title":"Cancer Commun."},{"issue":"23","key":"10.1016\/j.heliyon.2024.e34397_bib19","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1016\/j.molcel.2023.10.042","article-title":"SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation","volume":"83","author":"Zhang","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.heliyon.2024.e34397_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118077","article-title":"FTY720 induces ferroptosis and autophagy via PP2a\/AMPK pathway in multiple myeloma cells","volume":"260","author":"Zhong","year":"2020","journal-title":"Life Sci."},{"issue":"3\u20134","key":"10.1016\/j.heliyon.2024.e34397_bib21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s10495-023-01909-2","article-title":"Multiple myeloma with high expression of SLC7a11 is sensitive to erastin-induced ferroptosis","volume":"29","author":"Zhang","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.heliyon.2024.e34397_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcancer.2019.07.009","article-title":"PI3K\/Akt\/mTOR inhibitors in cancer: at the bench and bedside","volume":"59","author":"Alzahrani","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34397_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34397_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13046-022-02377-3","article-title":"TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K\/AKT pathway in bladder cancer","volume":"41","author":"Chi","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34397_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41419-021-03510-4","article-title":"Suppression of steroid 5alpha-reductase type I promotes cellular apoptosis and autophagy via PI3K\/Akt\/mTOR pathway in multiple myeloma","volume":"12","author":"Dou","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e34397_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.freeradbiomed.2023.04.003","article-title":"Targeting ABCB6 with nitidine chloride inhibits PI3K\/AKT signaling pathway to promote ferroptosis in multiple myeloma, Free","volume":"203","author":"Yin","year":"2023","journal-title":"Radic. Biol. Med."},{"issue":"49","key":"10.1016\/j.heliyon.2024.e34397_bib27","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1073\/pnas.2017152117","article-title":"Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis","volume":"117","author":"Yi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"24","key":"10.1016\/j.heliyon.2024.e34397_bib28","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1158\/0008-5472.CAN-21-1547","article-title":"A dual PI3K\/HDAC inhibitor induces immunogenic ferroptosis to potentiate cancer immune checkpoint therapy","volume":"81","author":"Fan","year":"2021","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34397_bib29","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34397_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"ClusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e34397_bib31","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ncb3064","article-title":"Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice","volume":"16","author":"Friedmann","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"7545","key":"10.1016\/j.heliyon.2024.e34397_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e34397_bib33","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-18-0430","article-title":"HER2 amplification in tumors activates PI3K\/akt signaling independent of HER3","volume":"78","author":"Ruiz-Saenz","year":"2018","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34397_bib34","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/s41375-020-0989-4","article-title":"Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma","volume":"35","author":"Allmeroth","year":"2021","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34397_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41418-023-01239-5","article-title":"TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7a11\/xCT K11-linked ubiquitination and degradation","volume":"31","author":"Wang","year":"2024","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34397_bib36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34397_bib37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34397_bib38","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"issue":"14","key":"10.1016\/j.heliyon.2024.e34397_bib39","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34397_bib40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s42255-022-00591-z","article-title":"Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo","volume":"4","author":"Murphy","year":"2022","journal-title":"Nat. Metab."},{"issue":"7784","key":"10.1016\/j.heliyon.2024.e34397_bib41","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34397_bib42","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/bjh.12039","article-title":"Combined targeting of MEK\/MAPK and PI3K\/Akt signalling in multiple myeloma","volume":"159","author":"Steinbrunn","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"23","key":"10.1016\/j.heliyon.2024.e34397_bib43","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1158\/0008-5472.CAN-23-1012","article-title":"Neurotransmitter receptor HTR2B regulates lipid metabolism to inhibit ferroptosis in gastric cancer","volume":"83","author":"Tu","year":"2023","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34397_bib44","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3324\/haematol.2015.124347","article-title":"Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial","volume":"100","author":"Merz","year":"2015","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34397_bib45","first-page":"1929","article-title":"Calcium silicate\/bortezomib combinatory therapy for multiple myeloma, Journal of materials chemistry. B","volume":"11","author":"Cao","year":"2023","journal-title":"Materials for biology and medicine"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e34397_bib46","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41419-019-2012-4","article-title":"CCL2 promotes macrophages-associated chemoresistance via MCPIP1 dual catalytic activities in multiple myeloma","volume":"10","author":"Xu","year":"2019","journal-title":"Cell Death Dis."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024104288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024104288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:57:02Z","timestamp":1773842222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024104288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":46,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2405844024104288"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34397","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AP-1 inhibitor induces ferroptosis via the PI3K\/AKT pathway in multiple myeloma cells","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e34397"}}